These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Calculation of QT shift in non clinical safety pharmacology studies. Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537 [TBL] [Abstract][Full Text] [Related]
15. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol. Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633 [TBL] [Abstract][Full Text] [Related]
16. Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessment. Fryer RM; Ng KJ; Chi L; Jin X; Reinhart GA J Pharmacol Toxicol Methods; 2015; 74():26-32. PubMed ID: 25946685 [TBL] [Abstract][Full Text] [Related]
17. Assessments of the QT/QRS restitution in perfused guinea-pig heart can discriminate safe and arrhythmogenic drugs. Osadchii OE J Pharmacol Toxicol Methods; 2017 Sep; 87():27-37. PubMed ID: 28552278 [TBL] [Abstract][Full Text] [Related]
18. Model-based evaluation of drug-induced QTc prolongation for compounds in early development. Dubois VF; Yu H; Danhof M; Della Pasqua O; Br J Clin Pharmacol; 2015 Jan; 79(1):148-61. PubMed ID: 25099645 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic modeling of drug-induced effect on the QT interval in conscious telemetered dogs. Ollerstam A; Visser SA; Persson AH; Eklund G; Nilsson LB; Forsberg T; Wiklund SJ; Gabrielsson J; Duker G; Al-Saffar A J Pharmacol Toxicol Methods; 2006; 53(2):174-83. PubMed ID: 16140023 [TBL] [Abstract][Full Text] [Related]
20. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model. Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]